Cost-Impact Analysis of a Novel Diagnostic Test to Assess Community-Acquired Pneumonia Etiology in the Emergency Department Setting: A Multi-Country European Study.

ABSTRACT:

Background

We aimed to estimate the economic and clinical impacts of a novel diagnostic test called LIAISON^® MeMed BV^® (LMMBV), which can differentiate bacterial from viral infections, in patients with community-acquired pneumonia (CAP) in emergency departments.

Methods

A cost-impact simulation model was developed to investigate the financial consequences of the introduction of LMMBV into the standard of care (SOC) diagnostic process in Italy, Germany, and Spain. Clinical outcomes were expressed as antibiotic patients and days saved, reduced hospital admissions, and shortened hospital length of stay (LOS). Cost savings were evaluated from the perspectives of third-party payers and hospitals. A deterministic sensitivity analysis (DSA) was carried out.

SUBMITTER: Houshmand H 

PROVIDER: S-EPMC10001249 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature